Sorafenib EP Impurity G | CAS 18585-06-3 - Request Quote
Sorafenib EP Impurity G
| SZ CAT No: | SZ-S012004 |
| CAS No | 18585-06-3 |
| Mol.F. | C10H9ClF3NO2 |
| Mol.Wt. | 267.6 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Sorafenib EP Impurity G is chemically Ethyl [4-chloro-3-(trifluoromethyl)phenyl]carbamate (as per EP). Sorafenib EP Impurity G is supplied with detailed characterization data compliant with regulatory guideline. Sorafenib EP Impurity G can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 18585-06-3
Purchase 18585-06-3
Order 18585-06-3
Enquire 18585-06-3
price of 18585-06-3
18585-06-3 Supplier
18585-06-3 Manufacturer
18585-06-3 Exporter
buy high quality Sorafenib EP Impurity G
Purchase Sorafenib EP Impurity G
Sorafenib EP Impurity G suppliers
Sorafenib EP Impurity G manufacturers
Sorafenib EP Impurity G price
Order Sorafenib EP Impurity G
Enquire Sorafenib EP Impurity G
Sorafenib EP Impurity G cost
Sorafenib EP Impurity G Supplier
Sorafenib EP Impurity G Distributor
Sorafenib EP Impurity G for Method Validation
Sorafenib Reference Standard
Sorafenib EP Impurity G for ANDA Filing
Sorafenib EP Impurity G for Forced Degradation Studies
Sorafenib EP Impurity G Identification Standards
Sorafenib EP Impurity G for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


